Scribe Therapeutics, Inc.

CIK 1853921 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Scribe Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 20268-K0001193125-26-380184
Sep 2, 202610-Q0001193125-26-380191
Aug 3, 2026SCHEDULE 13G0001346824-26-000210
Jul 30, 2026SCHEDULE 13D0000059478-26-000072
Jul 30, 2026SCHEDULE 13D0000902664-26-003281
Jul 29, 202640000947871-26-000734
Jul 29, 2026SCHEDULE 13D0000947871-26-000732
Jul 29, 202640000947871-26-000733
Jul 29, 202640001231919-26-000813
Jul 29, 202640001739090-26-000010
Jul 28, 202640000902664-26-003270
Jul 28, 202640002147277-26-000003
Jul 27, 202640002075052-26-000004
Jul 27, 2026424B40001193125-26-316503
Jul 27, 2026S-80001193125-26-316529
Jul 27, 20268-K0001193125-26-318263
Jul 27, 202640001282930-26-000004
Jul 27, 202640001781292-26-000007
Jul 27, 202640002127908-26-000004
Jul 27, 202640002130384-26-000004
Jul 27, 202640000902664-26-003254
Jul 27, 202640002127814-26-000004
Jul 24, 2026FWP0001193125-26-314757
Jul 23, 2026S-1MEF0001193125-26-314695
Jul 23, 202630001781292-26-000005